|
Pemetrexed 500 mg/m^2 Clinical Trials
1 actively recruiting trial across 1 location
Birmingham, Alabama1 trial
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
University of Alabama at Birmingham
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.